Cargando…

Immune inactivation by APOBEC3B enrichment predicts response to chemotherapy and survival in gastric cancer

Apolipoprotein B mRNA editing enzyme catalytic polypeptide 3B (APOBEC3B) plays an important role in tumor mutagenesis. However, its clinical significance in gastric cancer (GC) remains largely unknown. We enrolled a total of 482 GC patients from Zhongshan Hospital, Fudan University for immunohistoch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Siyu, Gu, Yun, Zhang, Haijian, Fei, Yuchao, Cao, Yifan, Fang, Hanji, Wang, Jieti, Lin, Chao, Zhang, Heng, Li, He, He, Hongyong, Xu, Jiejie, Li, Ruochen, Liu, Hao, Zhang, Weijuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451457/ https://www.ncbi.nlm.nih.gov/pubmed/34552824 http://dx.doi.org/10.1080/2162402X.2021.1975386

Ejemplares similares

Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+ T cells enriched gastric cancer patients
por: Jin, Kaifeng, et al.
Publicado: (2021)

Intratumoral IL-1R1 expression delineates a distinctive molecular subset with therapeutic resistance in patients with gastric cancer
por: Zhang, Puran, et al.
Publicado: (2022)

Intratumoral CXCR5(+)CD8(+)T associates with favorable clinical outcomes and immunogenic contexture in gastric cancer
por: Wang, Jieti, et al.
Publicado: (2021)

Somatic ARID1A mutation stratifies patients with gastric cancer to PD-1 blockade and adjuvant chemotherapy
por: Gu, Yun, et al.
Publicado: (2022)

Intratumoral PD-1(+)CD8(+) T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer
por: Yu, Kuan, et al.
Publicado: (2022)

Targeting myeloid checkpoint Siglec-10 reactivates antitumor immunity and improves anti-programmed cell death 1 efficacy in gastric cancer
por: Lv, Kunpeng, et al.
Publicado: (2023)

Impact of intratumoural CD96 expression on clinical outcome and therapeutic benefit in gastric cancer
por: Xu, Chang, et al.
Publicado: (2022)

Tumor-infiltrating podoplanin(+) cells in gastric cancer: clinical outcomes and association with immune contexture
por: Liu, Xin, et al.
Publicado: (2020)

C-type lectin receptor Dectin-1 blockade on tumour-associated macrophages improves anti-PD-1 efficacy in gastric cancer
por: Liu, Xin, et al.
Publicado: (2023)

CXC chemokine receptor 1 predicts postoperative prognosis and chemotherapeutic benefits for TNM II and III resectable gastric cancer patients
por: Cao, Yifan, et al.
Publicado: (2016)

Identification and validation of an immunogenic subtype of gastric cancer with abundant intratumoural CD103(+)CD8(+) T cells conferring favourable prognosis
por: Li, Ruochen, et al.
Publicado: (2020)

Intratumoral interleukin-9 delineates a distinct immunogenic class of gastric cancer patients with better prognosis and adjuvant chemotherapeutic response
por: Fang, H., et al.
Publicado: (2020)

Glycoprotein 130 is associated with adverse postoperative clinical outcomes of patients with late-stage non-metastatic gastric cancer
por: Cao, Yifan, et al.
Publicado: (2016)

Intratumoral CD103(+)CD4(+) T cell infiltration defines immunoevasive contexture and poor clinical outcomes in gastric cancer patients
por: Gu, Yun, et al.
Publicado: (2020)

High expression of C-C chemokine receptor 2 associates with poor overall survival in gastric cancer patients after surgical resection
por: Li, Ruochen, et al.
Publicado: (2016)

Prognostic value of stromal cell-derived factor 1 expression in patients with gastric cancer after surgical resection
por: Wang, Xuefei, et al.
Publicado: (2014)

Interleukin-13 receptor α2 is associated with poor prognosis in patients with gastric cancer after gastrectomy
por: Lin, Chao, et al.
Publicado: (2016)

Decreased expression of granulocyte-macrophage colony-stimulating factor is associated with adverse clinical outcome in patients with gastric cancer undergoing gastrectomy
por: Liu, Hao, et al.
Publicado: (2017)

Prognostic value, immune signature and molecular mechanisms of the APOBEC family members APOBEC1, APOBEC3A, APOBEC3G and APOBEC3H in pancreatic adenocarcinoma
por: Duan, Yunjie, et al.
Publicado: (2022)

APOBEC3A suppresses cervical cancer via apoptosis
por: Li, Zishuai, et al.
Publicado: (2023)

The Roles of APOBEC3G Complexes in the Incorporation of APOBEC3G into HIV-1
por: Ma, Jing, et al.
Publicado: (2013)

Associations between the single nucleotide polymorphisms of APOBEC3A, APOBEC3B and APOBEC3H, and chronic hepatitis B progression and hepatocellular carcinoma in a Chinese population
por: He, Xiuting, et al.
Publicado: (2019)

APOBECs and Herpesviruses
por: Cheng, Adam Z., et al.
Publicado: (2021)

Surgeons’ mental distress and risks after severe complications following radical gastrectomy in China: a nationwide cross-sectional questionnaire
por: He, Hongyong, et al.
Publicado: (2023)

Prognostic nomograms for gastric carcinoma after surgery to assist decision-making for postoperative treatment with chemotherapy cycles <9 or chemotherapy cycles ≥9
por: Li, Yifan, et al.
Publicado: (2022)

APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication
por: Seplyarskiy, Vladimir B., et al.
Publicado: (2016)

Efficient and precise base editing in rabbits using human APOBEC3A-nCas9 fusions
por: Liu, Zhiquan, et al.
Publicado: (2019)

APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer
por: Wang, Shixiang, et al.
Publicado: (2018)

Comprehensive bioinformatics analyses of APOBECs family and identification of APOBEC3D as the unfavorable prognostic biomarker in clear cell renal cell carcinoma
por: Zhu, Zhenpeng, et al.
Publicado: (2021)

DNA cytosine and methylcytosine deamination by APOBEC3B: enhancing methylcytosine deamination by engineering APOBEC3B
por: Fu, Yang, et al.
Publicado: (2015)

Up-regulation of interferon-a/APOBEC3G signal pathway potently inactivates HIV-1 infectivity in resting CD4-T cells
por: Chen, Keyang, et al.
Publicado: (2006)

APOBEC3A is an oral cancer prognostic biomarker in Taiwanese carriers of an APOBEC deletion polymorphism
por: Chen, Ting-Wen, et al.
Publicado: (2017)

Feline APOBEC3s, Barriers to Cross-Species Transmission of FIV?
por: Zhang, Zeli, et al.
Publicado: (2018)

The structural basis for HIV-1 Vif antagonism of human APOBEC3G
por: Li, Yen-Li, et al.
Publicado: (2023)

Single Purse-String Suture for Reinforcement of Duodenal Stump During Laparoscopic Radical Gastrectomy for Gastric Cancer
por: He, Hongyong, et al.
Publicado: (2019)

Model Structure of Human APOBEC3G
por: Zhang, Kun-Lin, et al.
Publicado: (2007)

Severe Encephalatrophy and Related Disorders From Long-Term Ketamine Abuse: A Case Report and Literature Review
por: Liu, Linying, et al.
Publicado: (2021)

Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer
por: Nik-Zainal, Serena, et al.
Publicado: (2014)

Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer
por: Olah, Csilla, et al.
Publicado: (2022)

High expression of galectin-7 associates with poor overall survival in patients with non-metastatic clear-cell renal cell carcinoma
por: Wang, Jieti, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t9mufqsrhkb7b877khg2dv0d8h